Cardlytics Files 2024 10-K
Ticker: CDLX · Form: 10-K · Filed: Mar 12, 2025 · CIK: 1666071
| Field | Detail |
|---|---|
| Company | Cardlytics, Inc. (CDLX) |
| Form Type | 10-K |
| Filed Date | Mar 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
Cardlytics dropped its 2024 10-K. Full financials for FY24 are out.
AI Summary
Cardlytics, Inc. filed its 2024 10-K on March 12, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The filing details the company's operations, financial position, and risk factors. Key financial data and operational metrics for 2024, 2023, and 2022 are presented, along with balance sheet information as of December 31, 2024 and 2023.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Cardlytics' financial health and strategic direction for the fiscal year 2024, enabling informed investment decisions.
Risk Assessment
Risk Level: medium — The filing contains standard risk factors inherent to technology and data processing companies, including market competition and regulatory changes.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Fiscal Year (Comparative period in the 10-K)
- 2022 — Fiscal Year (Comparative period in the 10-K)
Key Players & Entities
- Cardlytics, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-12 (date) — Filing date
FAQ
What is the primary business of Cardlytics, Inc. as described in the 10-K?
The filing indicates Cardlytics, Inc. operates in the Services-Computer Programming, Data Processing, etc. sector (SIC code 7370).
When was the 10-K for the fiscal year ending December 31, 2024, filed?
The 10-K was filed on March 12, 2025.
What are the key dates for the fiscal periods covered in this filing?
The filing covers the fiscal year ending December 31, 2024, and includes comparative data for 2023 and 2022.
Where is Cardlytics, Inc. headquartered?
Cardlytics, Inc. is headquartered in Atlanta, Georgia, with its business address at 675 Ponce de Leon Avenue, NE, Suite 4100.
What is the SEC file number for Cardlytics, Inc.'s 10-K filings?
The SEC file number is 001-38386.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 12, 2025 regarding Cardlytics, Inc. (CDLX).